一例子宫内膜透明细胞癌伴卵巢转移的病例报告及文献回顾
A Case Report of Endometrial Clear Cell Carcinoma with Ovarian Metastasis and a Literature Review
DOI: 10.12677/acm.2025.15123409, PDF,   
作者: 卓 倩：江苏大学淮安临床医学院(淮安市淮安医院)病理科，江苏 淮安；朱亚宁*：江苏省淮安市第一人民医院病理科，江苏 淮安
关键词: 子宫内膜透明细胞癌；卵巢透明细胞癌；双原发癌；转移癌；Endometrial Clear Cell Carcinoma； Ovarian Clear Cell Carcinoma； Dual Primary Cancer； Metastatic Cancer
摘要: 子宫内膜透明细胞癌(Endometrial clear cell carcinoma, ECCC)在子宫内膜癌中比较少见，侵袭性强，预后较差，除发生在子宫内膜外，还可以发生在卵巢、阴道和宫颈等。子宫内膜癌同时合并卵巢癌称为同步性子宫内膜和卵巢癌，子宫内膜和卵巢的恶性肿瘤可能存在同源性，两者的基本临床特征也没有明显差异，故准确区分原发性双癌或子宫内膜样癌转移至卵巢是具有挑战性的。本例患者子宫内膜癌和卵巢癌都是透明细胞癌，输卵管受累，诊断具有挑战性，文献中少见报道。
Abstract: Endometrial clear cell carcinoma (ECCC) is relatively rare among endometrial cancers, with strong invasiveness and a poor prognosis. Besides occurring in the endometrium, it can also develop in the ovary, vagina, and cervix. When endometrial cancer coexists with ovarian cancer, it is called synchronous endometrial and ovarian cancer. There may be homology between malignant tumors of the endometrium and ovary, and their basic clinical features do not show significant differences. Therefore, accurately distinguishing primary double cancers from endometrial-like cancer metastasizing to the ovary is challenging. In this case, both the endometrial cancer and ovarian cancer of the patient are clear cell carcinomas, with the fallopian tube involved. The diagnosis is challenging, and there are few reports in the literature.
文章引用：卓倩, 朱亚宁. 一例子宫内膜透明细胞癌伴卵巢转移的病例报告及文献回顾[J]. 临床医学进展, 2025, 15(12): 287-296. https://doi.org/10.12677/acm.2025.15123409

参考文献

[1] Gilks, C.B. and Kommoss, F. (2018) Synchronous Tumours of the Female Reproductive Tract. Pathology, 50, 214-221. [Google Scholar] [CrossRef] [PubMed]
[2] Zaino, R., Whitney, C., Brady, M.F., DeGeest, K., Burger, R.A. and Buller, R.E. (2001) Simultaneously Detected Endometrial and Ovarian Carcinomas—A Prospective Clinicopathologic Study of 74 Cases: A Gynecologic Oncology Group Study. Gynecologic Oncology, 83, 355-362. [Google Scholar] [CrossRef] [PubMed]
[3] Khalid, N., Ullah, F., Zafar, H., Anwer, A.W., Abbas, T., Shakeel, O., et al. (2020) Synchronous Primary Endometrial and Ovarian Cancers: Trends and Outcomes of the Rare Disease at a South Asian Tertiary Care Cancer Center. Cureus, 12, e9163. [Google Scholar] [CrossRef] [PubMed]
[4] 陈双凤, 朱晨辰, 周晴晴, 等. 子宫内膜和卵巢同期双原发癌的临床特征及分子分型特点分析[J]. 现代妇产科进展, 2022, 31(8): 573-578.
[5] Soliman, P.T., Slomovitz, B.M., Broaddus, R.R., Sun, C.C., Oh, J.C., Eifel, P.J., et al. (2004) Synchronous Primary Cancers of the Endometrium and Ovary: A Single Institution Review of 84 Cases. Gynecologic Oncology, 94, 456-462. [Google Scholar] [CrossRef] [PubMed]
[6] Scully, R.E. and Young, R.H. (1987) Metastasis Tumors of the Ovary IN: Blaustein’s Gynecologic Pathology of the Female Genital Tract. 3rd Edition, Springer-Verlag, 983-984.
[7] Ulbright, T.M. and Roth, L.M. (1985) Metastatic and Independent Cancers of the Endometrium and Ovary: A Clinicopathologic Study of 34 Cases. Human Pathology, 16, 28-34. [Google Scholar] [CrossRef] [PubMed]
[8] Li, Q., Cheng, X., Ji, J., Zhang, J. and Huang, W. (2016) The Application Value of Hnf-1β Transcription Factor in the Diagnosis of Ovarian Clear Cell Carcinoma. International Journal of Gynecological Pathology, 35, 66-71. [Google Scholar] [CrossRef] [PubMed]
[9] Němejcová, K., Tichá, I., Kleiblová, P., Bártů, M., Cibula, D., Jirsová, K., et al. (2015) Expression, Epigenetic and Genetic Changes of HNF1B in Endometrial Lesions. Pathology & Oncology Research, 22, 523-530. [Google Scholar] [CrossRef] [PubMed]
[10] Lim, D., Ip, P.P.C., Cheung, A.N.Y., Kiyokawa, T. and Oliva, E. (2015) Immunohistochemical Comparison of Ovarian and Uterine Endometrioid Carcinoma, Endometrioid Carcinoma with Clear Cell Change, and Clear Cell Carcinoma. American Journal of Surgical Pathology, 39, 1061-1069. [Google Scholar] [CrossRef] [PubMed]
[11] Asaka, S., Nakajima, T., Kugo, K., Kashiwagi, R., Yazaki, N., Miyamoto, T., et al. (2020) Immunophenotype Analysis Using CLDN18, CDH17, and PAX8 for the Subcategorization of Endocervical Adenocarcinomas in Situ: Gastric-Type, Intestinal-Type, Gastrointestinal-Type, and Müllerian-Type. Virchows Archiv, 476, 499-510. [Google Scholar] [CrossRef] [PubMed]
[12] Hoang, L.N., McConechy, M.K., Meng, B., McIntyre, J.B., Ewanowich, C., Gilks, C.B., et al. (2015) Targeted Mutation Analysis of Endometrial Clear Cell Carcinoma. Histopathology, 66, 664-674. [Google Scholar] [CrossRef] [PubMed]
[13] Ji, J.X., Cochrane, D.R., Tessier-Cloutier, B., Leung, S., Cheng, A.S., Chow, C., et al. (2019) Use of Immunohistochemical Markers (Hnf-1β, Napsin A, ER, CTH, and ASS1) to Distinguish Endometrial Clear Cell Carcinoma from Its Morphologic Mimics Including Arias-Stella Reaction. International Journal of Gynecological Pathology, 39, 344-353. [Google Scholar] [CrossRef] [PubMed]
[14] 邵长好, 贺红梅, 赵长燕. P16、P53、HE4在卵巢浆液性肿瘤中的表达及意义[J]. 临床和实验医学杂志, 2018, 17(20): 2198-2201.
[15] Kim, S.R., Cloutier, B.T., Leung, S., Cochrane, D., Britton, H., Pina, A., et al. (2020) Molecular Subtypes of Clear Cell Carcinoma of the Endometrium: Opportunities for Prognostic and Predictive Stratification. Gynecologic Oncology, 158, 3-11. [Google Scholar] [CrossRef] [PubMed]
[16] Talhouk, A., McConechy, M.K., Leung, S., Li-Chang, H.H., Kwon, J.S., Melnyk, N., et al. (2015) A Clinically Applicable Molecular-Based Classification for Endometrial Cancers. British Journal of Cancer, 113, 299-310. [Google Scholar] [CrossRef] [PubMed]
[17] Kobayashi, Y., Nakamura, K., Nomura, H., Banno, K., Irie, H., Adachi, M., et al. (2015) Clinicopathologic Analysis with Immunohistochemistry for DNA Mismatch Repair Protein Expression in Synchronous Primary Endometrial and Ovarian Cancers. International Journal of Gynecological Cancer, 25, 440-446. [Google Scholar] [CrossRef] [PubMed]
[18] Reijnen, C., Küsters‐Vandevelde, H.V.N., Ligtenberg, M.J.L., Bulten, J., Oosterwegel, M., Snijders, M.P.L.M., et al. (2020) Molecular Profiling Identifies Synchronous Endometrial and Ovarian Cancers as Metastatic Endometrial Cancer with Favorable Clinical Outcome. International Journal of Cancer, 147, 478-489. [Google Scholar] [CrossRef] [PubMed]
[19] Sachdeva, M., Blanc-Durand, F. and Tan, D. (2025) Controversies in the Management of Clear Cell Carcinoma of the Uterus and Ovary. International Journal of Gynecological Cancer, 35, Article ID: 101681. [Google Scholar] [CrossRef] [PubMed]

为你推荐